CSL Behring
Afstyla – Prelaunch Film

Our Task

Our job was to prepare the market launch of Afstyla, a treatment drug for haemophilia A patients. The type of campaign our customer CSL Behring was looking for was one that was both emotional and attention-grabbing. The communication was targeted at the entire CSL Behring staff worldwide as well as haematology specialists and haemophilia A patient organisations around the globe. The unique challenge here was that neither the drug itself nor its properties were to be named explicitly in the prelaunch phase.

Our Approach

An authentic and emotional film portraying the daily challenges of a haemophilia A patient. The film showed the effects and patient benefits of Afstyla – without going into too much detail.

More information?

GUNTHER TUTEIN
Managing Director
Send an email